To quantify the expression of IFN response genes, we compared the IFN transcriptional signature in patients P1, P2, and P3 and patients with systemic lupus erythematosus (SLE), a known type I IFN–associated disease, with that of healthy controls (23). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.